These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 18036588)

  • 21. AMPA/kainate-type glutamate receptor antagonist reduces progressive inner hair cell loss after transient cochlear ischemia.
    Hakuba N; Matsubara A; Hyodo J; Taniguchi M; Maetani T; Shimizu Y; Tsujiuchi Y; Shudou M; Gyo K
    Brain Res; 2003 Jul; 979(1-2):194-202. PubMed ID: 12850586
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Intrathecal co-administration of kappa opioid receptor agonists and NMDA receptor antagonists induces synergistic analgesia in rats].
    Li FC; Sun XJ; Hu WH; Jen MF
    Yao Xue Xue Bao; 1994; 29(12):881-6. PubMed ID: 7709739
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Implication of NMDA type glutamate receptors in neural regeneration and neoformation of synapses after excitotoxic injury in the guinea pig cochlea.
    d'Aldin CG; Ruel J; Assié R; Pujol R; Puel JL
    Int J Dev Neurosci; 1997 Jul; 15(4-5):619-29. PubMed ID: 9263038
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dynorphinergic mechanism mediating endomorphin-2-induced antianalgesia in the mouse spinal cord.
    Wu HE; Sun HS; Darpolar M; Leitermann RJ; Kampine JP; Tseng LF
    J Pharmacol Exp Ther; 2003 Dec; 307(3):1135-41. PubMed ID: 14557378
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Generalization of NMDA-receptor antagonists to the discriminative stimulus effects of kappa-opioid receptor agonists U-50,488H, but not TRK-820 in rats.
    Mori T; Nomura M; Yoshizawa K; Nagase H; Sawaguchi T; Narita M; Suzuki T
    J Pharmacol Sci; 2006 Feb; 100(2):157-61. PubMed ID: 16474203
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acute progesterone can recruit sex-specific neurochemical mechanisms mediating swim stress-induced and kappa-opioid analgesia in mice.
    Sternberg WF; Chesler EJ; Wilson SG; Mogil JS
    Horm Behav; 2004 Nov; 46(4):467-73. PubMed ID: 15465533
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of ACEA-1328, a NMDA receptor/glycine site antagonist, on U50,488H-induced antinociception and tolerance.
    Lutfy K; Doan P; Nguyen M; Weber E
    Eur J Pharmacol; 1999 Nov; 384(1):1-5. PubMed ID: 10611412
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Endogenous dynorphins: possible role in peripheral tinnitus.
    Sahley TL; Nodar RH; Musiek FE
    Int Tinnitus J; 1999; 5(2):76-91. PubMed ID: 10753426
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dynorphin uses a non-opioid mechanism to potentiate N-methyl-D-aspartate currents in single rat periaqueductal gray neurons.
    Lai SL; Gu Y; Huang LY
    Neurosci Lett; 1998 May; 247(2-3):115-8. PubMed ID: 9655606
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The opioid peptide dynorphin directly blocks NMDA receptor channels in the rat.
    Chen L; Gu Y; Huang LY
    J Physiol; 1995 Feb; 482 ( Pt 3)(Pt 3):575-81. PubMed ID: 7537820
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of the anticonvulsant U-54494A on cortical neuron excitability: comparison to the kappa agonist U-50488H.
    Ochoa MC; Vogelsang GD; Lum JT; VonVoigtlander PF; Piercey MF
    Life Sci; 1992; 50(17):1225-33. PubMed ID: 1349150
    [TBL] [Abstract][Full Text] [Related]  

  • 32. NMDA receptor blockage protects against permanent noise-induced hearing loss but not its potentiation by carbon monoxide.
    Chen GD; Kong J; Reinhard K; Fechter LD
    Hear Res; 2001 Apr; 154(1-2):108-15. PubMed ID: 11423221
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lack of evidence of kappa2-selective activation of G-proteins: kappa opioid receptor stimulation of [35S] GTPgammaS binding in guinea pig brain.
    Childers SR; Xiao R; Vogt L; Sim LJ
    Biochem Pharmacol; 1998 Jul; 56(1):113-20. PubMed ID: 9698095
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential effects of LY235959, a competitive antagonist of the NMDA receptor on kappa-opioid receptor agonist induced responses in mice and rats.
    Bhargava HN; Thorat SN
    Brain Res; 1997 Feb; 747(2):246-51. PubMed ID: 9045999
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Non-competitive antagonism of N-methyl-D-aspartate receptor inhibits tolerance to the analgesic action of U-50,488H, a kappa-opiate receptor agonist in the rat.
    Bhargava HN
    Gen Pharmacol; 1995 Sep; 26(5):1055-60. PubMed ID: 7557250
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential sensitivity of recombinant N-methyl-D-aspartate receptor subunits to inhibition by dynorphin.
    Brauneis U; Oz M; Peoples RW; Weight FF; Zhang L
    J Pharmacol Exp Ther; 1996 Dec; 279(3):1063-8. PubMed ID: 8968325
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dynorphin A (1-13) neurotoxicity in vitro: opioid and non-opioid mechanisms in mouse spinal cord neurons.
    Hauser KF; Foldes JK; Turbek CS
    Exp Neurol; 1999 Dec; 160(2):361-75. PubMed ID: 10619553
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Roles of kappa-opioid receptor agonists in learning and memory impairment in animal models.
    Hiramatsu M; Kameyama T
    Methods Find Exp Clin Pharmacol; 1998 Sep; 20(7):595-9. PubMed ID: 9819804
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of ketamine, dextromethorphan, and MK-801 on cochlear dysfunction induced by transient ischemia.
    Tabuchi K; Tsuji S; Wada T; Ito Z; Hara A; Kusakari J
    Ann Otol Rhinol Laryngol; 2002 Jan; 111(1):44-9. PubMed ID: 11800369
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The NMDA receptor antagonists, LY274614 and MK-801, and the nitric oxide synthase inhibitor, NG-nitro-L-arginine, attenuate analgesic tolerance to the mu-opioid morphine but not to kappa opioids.
    Elliott K; Minami N; Kolesnikov YA; Pasternak GW; Inturrisi CE
    Pain; 1994 Jan; 56(1):69-75. PubMed ID: 7512709
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.